Skip links

Blog

ecog-acrin-completes-first-trial-of-black-patients-with-early-stage-breast-cancer

ECOG-ACRIN completes first trial of Black patients with early-stage breast cancer

Black patients with early-stage breast cancer who were treated with docetaxel chemotherapy every 3 weeks had less drug-induced peripheral neuropathy and significantly fewer dose reductions compared to those who received weekly paclitaxel, according to a trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). Study EAZ171 is the
new-pathways-for-treating-never-smoker-lung-cancer-revealed

New pathways for treating never-smoker lung cancer revealed

The primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women. While approximately 80% of never-smoking lung cancer patients are prescribed targeted therapies that focus on mutations in proteins such as EGFR and
neoadjuvant-immunotherapy-for-early-stage-melanoma-shows-positive-results

Neoadjuvant Immunotherapy for early stage melanoma shows positive results

Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Fifty-nine percent of patients responds so well to this therapy that adjuvant treatment is no longer needed, according to the results of the NADINA study that were published today. Credit: Netherlands Cancer
breakthrough-in-using-bispecific-antibodies-for-solid-tumors

Breakthrough in using bispecific antibodies for solid tumors

Professor Seung-Woo Lee and PhD candidate Kun-Joo Lee from the Department of Life Sciences at Pohang University of Science and Technology (POSTECH), in collaboration with NeoImmuneTech Director Donghoon Choi and Professors Dae Hee Kim and Sun Shim Choi from Kangwon National University, have revealed a
one-in-four-thai-concerned-about-colorectal-cancer-screening-cost

One in four Thai concerned about colorectal cancer screening cost

According to research led by Prof. Varut Lohsiriwat, Professor of Surgery, Division of General Surgery (Section of Colorectal Surgery) of Siriraj Hospital, at Mahidol University, CRC is the third most common cancer in Thailand, accounting for 11% of the cancer burden. It is the only
uta-researcher-recognized-for-data-science-leadership

UTA researcher recognized for data science leadership

Xinlei “Sherry” Wang, director for research in the Division of Data Science at The University of Texas at Arlington, has been named a 2024 fellow of the American Statistical Association (ASA). Credit: Photo courtesy UT Arlington Xinlei “Sherry” Wang, director for research in the Division of Data Science at The
study:-access-to-targeted-lung-cancer-drug-is-cost-prohibitive-globally

Study: Access to targeted lung cancer drug is cost-prohibitive globally

MIAMI, FLORIDA (May 30, 2024) – Many countries with national healthcare systems or payers such as insurance companies use cost-effectiveness analyses to decide whether to cover new medicines, balancing treatment costs with potential health benefits. Credit: Photo by Sylvester MIAMI, FLORIDA (May 30, 2024) –
Explore
Drag